European Markets Retreat as Tech Sell-off Deepens
The CAC 40 index fell 0.7% to approximately 8,000 points on Tuesday, marking a third consecutive session of losses as investors retreated from high-valuation technology and semiconductor stocks. The downturn reflects broader global market anxiety regarding the return on investment for massive artificial intelligence infrastructure spending, with major European indices tracking declines in the U.S. Nasdaq 100.
Why are tech stocks under pressure?
The current market volatility is driven by investor skepticism regarding the high valuations of semiconductor firms and “hyperscaler” cloud providers. According to market data, major tech entities including Nvidia, AMD, Broadcom, and Micron have faced significant selling pressure. Investors are increasingly questioning whether the heavy capital expenditure (capex) dedicated to AI development will yield the anticipated financial returns. This uncertainty has prompted a rotation out of the high-performing tech sector that led market gains earlier this year.
How are individual stocks reacting to the volatility?
The sell-off has disproportionately impacted semiconductor and luxury goods sectors in Paris.
* STMicroelectronics: Shares fell more than 7%, making it the leading decliner on the CAC 40.
* Soitec: The company recorded a decline exceeding 10% during Tuesday’s session.
* Hermès: The luxury group dropped 2%, marking its third straight day of losses. HSBC analysts recently downgraded the stock from “buy” to “hold,” lowering their price target from €2,100 to €1,870 ahead of second-quarter earnings.
* L’Oréal: Shares dipped 0.5% after Deutsche Bank downgraded the stock to “sell.” Analysts cited concerns over slowing demand in China and increased competition from Chinese exporters as primary headwinds for the second half of the year.
Are there sectors showing resilience?
Despite the overall market dip, select companies have posted gains following specific corporate developments. Sanofi shares rose 1.6% to €73.70 after the European Commission approved its drug, Cenrifki (tolebrutinib), for the treatment of secondary progressive multiple sclerosis. Additionally, Capgemini shares climbed 2.5% to €90 following an adjustment in price targets by Goldman Sachs.
What is the status of the European automotive sector?
European automakers faced renewed pressure following the release of May registration data from the European Automobile Manufacturers’ Association (ACEA). Renault shares dropped 5% to €26.40, while Stellantis declined 4% to €5.43.
While total new vehicle registrations in Europe increased by 3.2%—marking the fourth consecutive month of growth—the sector faces structural shifts. According to ACEA reports, growth is being driven primarily by affordable electric and hybrid models, where traditional European manufacturers are increasingly losing market share to Chinese brands. Battery electric vehicles, plug-in hybrids, and standard hybrids now account for over two-thirds of all new registrations in the region.
Market Outlook
Investors are pivoting their focus toward upcoming earnings reports to gauge the health of the tech sector. Key indicators expected this week include:
* Cerebras Systems: Earnings results scheduled for Tuesday.
* Micron Technology: Financial updates expected Wednesday evening.
Market participants remain cautious, as these reports are expected to provide a clearer picture of whether the current tech correction is a short-term adjustment or a sign of cooling demand for AI-related infrastructure.